This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 1 from Patent US 20060122119
General Information
DRACP ID DRACP01265
Peptide Name Sequence 1 from Patent US 20060122119
Sequence EXAGIGILX
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic construct
Type Synthetic peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification X(2)=A or P; X(9)=T or Y
Chiral L
Physicochemical Information
Formula C30H49N7O8
Absent amino acids CDFHKMNPQRSTVWY
Common amino acids GIX
Mass 99865
Pl 3.85
Basic residues 0
Acidic residues 1
Hydrophobic residues 4
Net charge -1
Boman Index 1164
Hydrophobicity 114.44
Aliphatic Index 141.11
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2006/0122119 A1
Patent Title Peptides for use in antitumor immunotherapy.
Other Iinformation Granted Patent Family: 10s / 10ex; Family Jurisdictions: CA, AU, FR, WO, US, EP, JP; Legal Status: Discontinued; Application No: 50633405; Filed:May 25, 2005; Published: Jun 8, 2006; Earliest Priority: Mar 4, 2002
Other Published ID CA2477762A1 EP1481009A2 WO2003074565A2 WO2003074565A3
This work is licensed under a Creative Commons Attribution 4.0 International License.